A Review of Depsipeptide and Other Histone Deacetylase Inhibitors in Clinical Trials

Publisher： Bentham Science Publishers

E-ISSN： 1873-4286|10|19|2289-2298

ISSN： 1381-6128

Source： Current Pharmaceutical Design, Vol.10, Iss.19, 2004-07, pp. : 2289-2298

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Histone deacetylase inhibitors: from target to clinical trials

By Kelly William K   O’Connor Owen A   Marks Paul A  

Expert Opinion on Investigational Drugs, Vol. 11, Iss. 12, 2002-12 ,pp. : 1695-1713

Informa Healthcare

Access to resources Recommend Favorite

Histone Deacetylase Inhibitors: Current Status and Overview of Recent Clinical Trials

By Xujun   Ezzeldin Hany H.   Diasio Robert B.  

Drugs, Vol. 69, Iss. 14, 2009-10 ,pp. : 1911-1934

Adis International

Access to resources Recommend Favorite

Histone deacetylase inhibitors in clinical development

By Rosato Roberto R   Grant Steven  

Expert Opinion on Investigational Drugs, Vol. 13, Iss. 1, 2004-01 ,pp. : 21-38

Informa Healthcare

Access to resources Recommend Favorite

Modifying histones to tame cancer: clinical development of sodium phenylbutyrate and other histone deacetylase inhibitors

By Gore S.D.   Carducci M.A.  

Expert Opinion on Investigational Drugs, Vol. 9, Iss. 12, 2000-12 ,pp. : 2923-2934

Informa Healthcare

Access to resources Recommend Favorite

Histone Deacetylase Inhibitors in Cancer Treatment: A Review of the Clinical Toxicity and the Modulation of Gene Expression in Cancer Cells

By  

Current Pharmaceutical Biotechnology, Vol. 8, Iss. 6, 2007-12 ,pp. : 388-400

Bentham Science Publishers

Access to resources Recommend Favorite